featured
Dose Reductions of Bleomycin and Vincristine Do Not Affect Efficacy in Advanced Hodgkin's Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials
J. Clin. Oncol 2015 Jun 22;[EPub Ahead of Print], H Haverkamp, B Böll, DA Eichenauer, S Sasse, M Fuchs, P Borchmann, V Diehl, A Engert, B von TresckowFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.